1800-272-662
Shopping Cart 0
countryflagAU
Login

Avita Medical Ltd

Healthcare US RCEL

4.9USD
-0.06(1.21%)

Last update at 2026-03-10T20:00:00Z

Day Range

4.865.13
LowHigh

52 Week Range

7.5121.70
LowHigh

Fundamentals

  • Previous Close 4.96
  • Market Cap222.65M
  • Volume132239
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-49.16300M
  • Revenue TTM50.70M
  • Revenue Per Share TTM1.99
  • Gross Profit TTM 28.38M
  • Diluted EPS TTM-1.88

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Analyst Recommendations

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Type yearly yearly yearly yearly yearly
Date 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Income before tax -26.62900M - -42.02600M -24.75004M -24.75004M
Minority interest - - - - 0.00000M
Net income -26.66500M - -42.03000M -24.62408M -24.62408M
Selling general administrative 23.33M - 34.62M 12.67M 12.67M
Selling and marketing expenses 21.91M - 14.81M 12.31M 12.31M
Gross profit 28.38M - 11.29M 4.21M 4.21M
Reconciled depreciation 0.57M - 0.71M 0.47M 0.26M
Ebit -27.50500M -25.07600M -41.99300M -24.72359M -24.72359M
Ebitda -26.04500M - -41.52800M -24.72359M -24.72359M
Depreciation and amortization 1.46M - 0.47M 0.00000M 0.00000M
Non operating income net other - - - - 0.00000M
Operating income -27.50500M - -42.67900M -24.72359M -24.72359M
Other operating expenses 61.93M 1.59M 56.94M 30.44M 30.44M
Interest expense 0.02M 0.00000M 0.03M 0.03M 0.03M
Tax provision 0.04M - 0.04M 0.00400M -0.12597M
Interest income - - - - -
Net interest income -0.01600M - -0.02200M -0.03300M -0.02645M
Extraordinary items - - - - 0.00000M
Non recurring - - - - 0.00000M
Other items - - - - 0.00000M
Income tax expense 0.04M 0.04M 0.00400M -0.12597M -0.12597M
Total revenue 34.42M - 14.26M 5.40M 5.40M
Total operating expenses 55.88M - 53.97M 29.25M 29.25M
Cost of revenue 6.04M - 2.97M 1.19M 1.19M
Total other income expense net 0.88M - 0.69M 0.32M 0.32M
Discontinued operations - - - - 0.00000M
Net income from continuing ops -26.66500M - -26.58300M -42.03000M -24.62408M
Net income applicable to common shares -26.66500M -25.14200M -26.58300M -42.03000M -25.10200M
Preferred stock and other adjustments - - - - 0.00000M
Breakdown 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Type yearly yearly yearly yearly yearly
Date 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Total assets 98.26M - 82.46M 25.73M 25.73M
Intangible assets 0.47M - 0.36M 0.22M 0.22M
Earning assets - - - - -
Other current assets 2.48M 0.20M 0.99M 1.09M 1.09M
Total liab 13.52M - 10.06M 4.87M 4.87M
Total stockholder equity 84.74M - 72.40M 20.86M 20.86M
Deferred long term liab - 0.50M 0.61M - 0.00000M
Other current liab 6.88M 0.35M 3.38M 0.46M 0.46M
Common stock 0.00300M 0.00300M 0.00300M 143.06M 143.06M
Capital stock 0.00300M - 0.00300M 0.00300M 143.06M
Retained earnings -262.58800M -235.92300M -194.91300M -128.68946M -128.68946M
Other liab 2.52M 1.33M 1.58M 0.43M 0.47M
Good will - - - - 0.00000M
Other assets 1.36M 0.94M 0.76M 0.00000M 0.00000M
Cash 18.16M - 73.64M 20.30M 20.30M
Cash and equivalents - - - - -
Total current liabilities 10.69M 9.15M 7.71M 4.40M 4.40M
Current deferred revenue 0.19M - - - -
Net debt -17.24600M - -71.72200M -20.26041M -20.26041M
Short term debt 0.61M - 0.88M - 0.00000M
Short long term debt - - - - 0.00000M
Short long term debt total 0.92M - 1.92M 0.04M 0.04M
Other stockholder equity 339.70M 8.06M 259.17M 29.79M 29.79M
Property plant equipment 2.05M 2.81M 2.94M 3.71M 1.31M
Total current assets 87.46M 92.13M 78.39M 24.22M 24.22M
Long term investments 6.93M - - - 0.00000M
Net tangible assets 84.28M 104.18M 115.18M 72.04M 20.61M
Short term investments 61.18M - - - 0.00000M
Net receivables 4.96M 3.51M 2.43M 2.09M 2.09M
Long term debt - - - - 0.00000M
Inventory 2.12M 2.13M 1.12M 0.74M 0.74M
Accounts payable 3.00M 2.71M 4.33M 3.95M 3.95M
Total permanent equity - - - - 0.00000M
Noncontrolling interest in consolidated entity - - - - 0.00000M
Temporary equity redeemable noncontrolling interests - - - - 0.00000M
Accumulated other comprehensive income 7.63M - 8.15M 6.49M 6.49M
Additional paid in capital - - - - 0.00000M
Common stock total equity - - 0.00300M 0.00300M 143.06M
Preferred stock total equity - - - - 0.00000M
Retained earnings total equity - - - - 0.00000M
Treasury stock - - - - 0.00000M
Accumulated amortization - - - - 0.00000M
Non currrent assets other 1.36M - 0.00100M 0.00000M 0.00000M
Deferred long term asset charges - - - - 0.00000M
Non current assets total 10.81M - 4.08M 1.51M 1.51M
Capital lease obligations 0.92M - 0.88M 1.92M 0.04M
Long term debt total - - - - 0.00145M
Breakdown 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Type yearly yearly yearly yearly yearly
Date 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Investments -19.33200M -49.55000M -1.17400M -0.84700M -1.25684M
Change to liabilities 0.03M 0.31M -0.69300M 2.44M 2.24M
Total cashflows from investing activities -19.33200M -50.20800M -1.17400M -0.84700M -1.22700M
Net borrowings - -0.00200M -0.01100M -0.04200M -0.06200M
Total cash from financing activities 0.90M 64.06M 77.06M 77.06M 28.92M
Change to operating activities -0.45800M -0.39100M -4.51900M 0.09M 2.31M
Net income -26.66500M -25.14200M -42.03000M -24.62408M -24.62408M
Change in cash -37.54800M -4.25400M 53.47M -39.62328M -19.24928M
Begin period cash flow 55.71M 110.95M 20.37M 20.37M 10.38M
End period cash flow 18.16M 55.71M 73.84M -19.24928M -19.24928M
Total cash from operating activities -19.09000M -18.03700M -22.74700M -19.24928M -19.24928M
Issuance of capital stock 0.00000M - 69.11M 81.70M 31.54M
Depreciation 0.57M 0.67M 0.47M 0.26M 0.26M
Other cashflows from investing activities - - - - 0.00000M
Dividends paid - - - - 0.00000M
Change to inventory -0.37100M -0.14400M -0.46800M 0.07M 0.07M
Change to account receivables -0.39500M -1.19300M -0.72900M -0.72900M -1.29100M
Sale purchase of stock - - - - 1.22M
Other cashflows from financing activities 0.90M -5.10900M -4.60300M -4.60300M -2.61906M
Change to netincome 7.87M 7.56M 6.85M 17.49M 2.31M
Capital expenditures 0.53M 0.49M 0.85M 0.85M 1.26M
Change receivables - - - - 0.00000M
Cash flows other operating - - - - 0.00000M
Exchange rate changes - - - - 0.00000M
Cash and cash equivalents changes - - - - 0.00000M
Change in working capital -1.19600M - 1.33M 3.35M 3.35M
Stock based compensation 7.00M - 16.59M 1.95M 1.95M
Other non cash items 1.21M - 0.50M 0.06M 0.06M
Free cash flow -19.61500M - -23.59400M -20.09628M -19.24928M

Peer Comparison

Sector: Healthcare Industry: Medical Devices

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
RCEL
Avita Medical Ltd		 -0.06 1.21% 4.90 - - 5.07 5.17 4.12 -6.1664
ABT
Abbott Laboratories		 -2.1 1.86% 110.55 37.15 23.15 4.67 4.97 4.88 19.38
SYK
Stryker Corporation		 -7.27 1.99% 358.65 44.07 24.94 5.51 6.12 6.05 25.73
MDT
Medtronic PLC		 -1.45 1.59% 89.89 26.60 15.87 3.35 2.08 3.90 14.12
BSX
Boston Scientific Corp		 -1.94 2.70% 69.96 68.17 24.57 5.85 4.26 6.46 26.80

Reports Covered

Stock Research & News

View All

Profile

AVITA Medical, Inc., together with its subsidiaries, operates as a regenerative medicine company in the United States and internationally. The company's lead product is the RECELL System, a cell harvesting device used for the treatment of thermal burn wounds, full-thickness skin defects, and repigmentation of stable depigmented vitiligo lesions. It develops RECELL GO to control the manual process of disaggregation, filtration, and soak time. The company was formerly known as AVITA Therapeutics, Inc. AVITA Medical, Inc. was incorporated in 2020 and is headquartered in Valencia, California.

Avita Medical Ltd

28159 Avenue Stanford, Valencia, CA, United States, 91355

Key Executives

Name Title Year Born
Mr. James M. Corbett CEO, Pres & Exec. Director 1958
Mr. Michael Bria Holder MBA Chief Financial Officer 1963
Ms. Kathy M. McGee Chief Operating Officer 1966
Mr. Andrew Quick Chief Technology Officer 1971
Ms. Donna Shiroma Gen. Counsel & Sec. 1962
Ms. Erin Liberto Chief Commercial Officer 1975
Mr. David Fencil VP of Global Operations NA
Ms. Debbie Garner VP of Global Marketing NA
Mr. James M. Corbett CEO, President & Executive Director 1958
Mr. David O'Toole Chief Financial Officer 1959

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.